Victoza has been on the market in Europe since last year. It's used to treat the early stages of type 2. Victoza has been so successful in reducing patients' weight that the company Novo Nordisk is considering testing whether Victoza could be used to treat severe obesity – a condition often associated with diabetes. Novo is now deciding how to run final-stage trials to test whether Victoza could be used to treat obesity and using the drug for this application could still be five years away. But if successful, it could signal a move by Novo into prevention of diabetes as well as the treatment of a condition which currently affects about 285m people and is expected to affect 483m people by 2030.
1000 Calorie Challenge Click Here!
Source: Telegraph.uk
.jpg)
1 comments:
Read the Victoza warning. . . . .yeah, this stuff is safe:
In animal studies, Victoza® caused thyroid tumors—including thyroid cancer—in some rats and mice. It is not known whether Victoza® causes thyroid tumors or a type of thyroid cancer called medullary thyroid cancer (MTC) in people which may be fatal if not detected and treated early. Do not use Victoza® if you or any of your family members have a history of MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). While taking Victoza®, tell your doctor if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Inflammation of the pancreas (pancreatitis) may be severe and lead to death. Before taking Victoza®, tell your doctor if you have had pancreatitis, gallstones, a history of alcoholism, or high blood triglyceride levels since these medical conditions make you more likely to get pancreatitis.
Post a Comment